Xu Hướng Xuất Bản Nghiên Cứu Về U Ngu Emirates Trong Thời Gian 2001–2021: Phân Tích Thống Kê Bibliometric Trong 20 Năm

Xiang Gu1,2, Minyue Xie1,2, Renbing Jia1,2, Shengfang Ge1,2
1Department of Ophthalmology, Ninth People’s Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China
2Shanghai Key Laboratory of Orbital Diseases and Ocular Oncology, Shanghai JiaoTong University School of Medicine, Shanghai, China

Tóm tắt

Nền Tảng: U nguyên bào võng mạc là loại ung thư nội nhãn nguyên phát phổ biến nhất ở trẻ em. Mặc dù tỷ lệ sống sót cao và việc bảo tồn mắt nhờ các phương pháp điều trị khác nhau, u nguyên bào võng mạc vẫn là một căn bệnh gây gánh nặng đáng kể cho các nước đang phát triển. Nghiên cứu của chúng tôi đã cố gắng phân tích các xu hướng nghiên cứu trong lĩnh vực u nguyên bào võng mạc và so sánh đóng góp từ các quốc gia, tổ chức, tạp chí và tác giả khác nhau.

Phương Pháp: Chúng tôi đã thu thập tất cả các công trình xuất bản liên quan đến u nguyên bào võng mạc từ năm 2001 đến 2021 từ cơ sở dữ liệu Web of Science. Microsoft Excel và VOSviewer đã được sử dụng để thu thập dữ liệu xuất bản, phân tích các xu hướng xuất bản và trực quan hóa các kết quả liên quan.

Từ khóa

#u nguyên bào võng mạc #xu hướng nghiên cứu #phân tích bibliometric #dữ liệu xuất bản #nghiên cứu lâm sàng #hóa trị liệu #nghiên cứu quản lý.

Tài liệu tham khảo

Dimaras, 2012, Retinoblastoma, Lancet., 379, 1436, 10.1016/S0140-6736(11)61137-9

Kivelä, 2009, The epidemiological challenge of the most frequent eye cancer: retinoblastoma, an issue of birth and death, Br J Ophthalmol., 93, 1129, 10.1136/bjo.2008.150292

Jain, 2019, Retinoblastoma in Asia, Eye., 33, 87, 10.1038/s41433-018-0244-7

MacCarthy, 2006, Retinoblastoma incidence and survival in European children (1978-1997). Report from the Automated Childhood Cancer Information System project, Eur J Cancer., 42, 2092, 10.1016/j.ejca.2006.06.003

2009, Can J Ophthalmol., 44, S1, 10.1016/S0008-4182(09)80180-4

Abramson, 1998, Presenting signs of retinoblastoma, J Pediatr, 132, 505, 10.1016/S0022-3476(98)70028-9

Rao, 2017, Retinoblastoma, Indian J Pediatr., 84, 937, 10.1007/s12098-017-2395-0

de Jong, 2014, Diagnostic performance of magnetic resonance imaging and computed tomography for advanced retinoblastoma: a systematic review and meta-analysis, Ophthalmology., 121, 1109, 10.1016/j.ophtha.2013.11.021

Karcioglu, 2002, Fine needle aspiration biopsy (FNAB) for retinoblastoma, Retina., 22, 707, 10.1097/00006982-200212000-00004

Wilson, 2011, A clinicopathological correlation of 67 eyes primarily enucleated for advanced intraocular retinoblastoma, Br J Ophthalmol., 95, 553, 10.1136/bjo.2009.177444

Fabian, 2018, The management of retinoblastoma, Oncogene., 37, 1551, 10.1038/s41388-017-0050-x

Shields, 2006, The International Classification of Retinoblastoma predicts chemoreduction success, Ophthalmology., 113, 2276, 10.1016/j.ophtha.2006.06.018

Yamane, 2004, The technique of ophthalmic arterial infusion therapy for patients with intraocular retinoblastoma, Int J Clin Oncol., 9, 69, 10.1007/s10147-004-0392-6

Shields, 2016, Intravitreous chemotherapy for active vitreous seeding from retinoblastoma: outcomes after 192 consecutive injections. The 2015 Howard Naquin Lecture, Retina., 36, 1184, 10.1097/IAE.0000000000000903

Abramson, 2016, Intra-arterial chemotherapy (ophthalmic artery chemosurgery) for group D retinoblastoma, PLoS ONE., 11, e0146582, 10.1371/journal.pone.0146582

Zhao, 2020, Bibliometric analysis of ATAC-Seq and its use in cancer biology via nucleic acid detection, Front Med., 7, 584728, 10.3389/fmed.2020.584728

Tao, 2020, COVID-19 will stimulate a new coronavirus research breakthrough: a 20-year bibliometric analysis, Ann Transl Med., 8, 528, 10.21037/atm.2020.04.26

Li, 2020, Research trends and performances of breast reconstruction: a bibliometric analysis, Ann Transl Med., 8, 1529, 10.21037/atm-20-3476

Stout, 2018, A bibliometric analysis of the landscape of cancer rehabilitation research (1992-2016), J Natl Cancer Inst., 110, 815, 10.1093/jnci/djy108

Xie, 2020, Publication trends of research on uveal melanoma during 2000-2020: a 20-year bibliometric study, Ann Transl Med., 8, 1463, 10.21037/atm-20-3700

Yao, 2020, Publication trends of research on sepsis and host immune response during 1999-2019: a 20-year bibliometric analysis, Int J Biol Sci., 16, 27, 10.7150/ijbs.37496

Ma, 2020, Global research trends on prostate diseases and erectile dysfunction: a bibliometric and visualized study, Front Oncol., 10, 627891, 10.3389/fonc.2020.627891

Qu, 2018, The 100 most influential publications in asthma from 1960 to 2017: a bibliometric analysis, Respir Med., 137, 206, 10.1016/j.rmed.2018.03.014

Wang, 2016, Trends of triple negative breast cancer research (2007-2015): a bibliometric study, Medicine., 95, e5427, 10.1097/MD.0000000000005427

Zhao, 2018, Bibliometric analysis of global scientific activity on umbilical cord mesenchymal stem cells: a swiftly expanding and shifting focus, Stem Cell Res Ther., 9, 32, 10.1186/s13287-018-0785-5

Mendoza, 2015, The biology of retinoblastoma, Prog Mol Biol Transl Sci., 134, 503, 10.1016/bs.pmbts.2015.06.012

Dimaras, 2015, Retinoblastoma genetics in India: from research to implementation, Indian J Ophthalmol., 63, 219, 10.4103/0301-4738.156917

Abramson, 2008, A phase I/II study of direct intraarterial (ophthalmic artery) chemotherapy with melphalan for intraocular retinoblastoma initial results, Ophthalmology., 115, 1398, 10.1016/j.ophtha.2007.12.014

Gobin, 2011, Intra-arterial chemotherapy for the management of retinoblastoma: four-year experience, Arch Ophthalmol., 129, 732, 10.1001/archophthalmol.2011.5

Abramson, 2015, Treatment of retinoblastoma in 2015: agreement and disagreement, JAMA Ophthalmol., 133, 1341, 10.1001/jamaophthalmol.2015.3108

Laurie, 2006, Inactivation of the p53 pathway in retinoblastoma, Nature., 444, 61, 10.1038/nature05194

Chen, 2004, Cell-specific effects of RB or RB/p107 loss on retinal development implicate an intrinsically death-resistant cell-of-origin in retinoblastoma, Cancer Cell., 5, 539, 10.1016/j.ccr.2004.05.025

Zhang, 2012, A novel retinoblastoma therapy from genomic and epigenetic analyses, Nature., 481, 329, 10.1038/nature10733

Ancona-Lezama, 2020, Modern treatment of retinoblastoma: A 2020 review, Indian J Ophthalmol., 68, 2356, 10.4103/ijo.IJO_721_20

Munier, 2017, First-line intra-arterial versus intravenous chemotherapy in unilateral sporadic group D retinoblastoma: evidence of better visual outcomes, ocular survival and shorter time to success with intra-arterial delivery from retrospective review of 20 years of treatment, Br J Ophthalmol., 101, 1086, 10.1136/bjophthalmol-2016-309298

Abramson, 2017, Ophthalmic artery chemosurgery for eyes with advanced retinoblastoma, Ophthalmic Genet., 38, 16, 10.1080/13816810.2016.1244695

Funes, 2018, Feasibility and results of an intraarterial chemotherapy program for the conservative treatment of retinoblastoma in Argentina, Pediatr Blood Cancer., 65, e27086, 10.1002/pbc.27086

Dimaras, 2015, Retinoblastoma, Nat Rev Dis Primers., 1, 15021, 10.1038/nrdp.2015.62

Munier, 2019, Conservative management of retinoblastoma: Challenging orthodoxy without compromising the state of metastatic grace. “Alive, with good vision and no comorbidity”., Prog Retin Eye Res, 73, 100764, 10.1016/j.preteyeres.2019.05.005

Kiratli, 2017, Intravitreal chemotherapy in the management of vitreous disease in retinoblastoma, Eur J Ophthalmol., 27, 423, 10.5301/ejo.5000921

Yousef, 2020, Intravitreal melphalan chemotherapy for vitreous seeds in retinoblastoma, J Ophthalmol., 2020, 8628525, 10.1155/2020/8628525

Yu, 2020, Effectiveness of intravitreal chemotherapy-assisted endoresection in monocular patients with group D retinoblastoma, BMC Cancer., 20, 808, 10.1186/s12885-020-07314-1

Yeung, 2019, A literature analysis on anti-vascular endothelial growth factor therapy (anti-VEGF) using a bibliometric approach, Naunyn Schmiedebergs Arch Pharmacol., 392, 393, 10.1007/s00210-019-01629-y

Stathopoulos, 2019, Intravitreal anti-vascular endothelial growth factor for the management of neovascularization in retinoblastoma after intravenous and/or intraarterial chemotherapY: long-term outcomes in a series of 35 eyes, Retina., 39, 2273, 10.1097/IAE.0000000000002339

Sun, 2020, Long noncoding RNA SNHG14 promotes the aggressiveness of retinoblastoma by sponging microRNA-124 and thereby upregulating STAT3, Int J Mol Med., 45, 1685, 10.3892/ijmm.2020.4547

Dong, 2020, Long noncoding RNA LINC00324 promotes retinoblastoma progression by acting as a competing endogenous RNA for microRNA-769-5p, thereby increasing STAT3 expression, Aging., 12, 7729, 10.18632/aging.103075

Wang, 2020, CircDHDDS/miR-361-3p/WNT3A axis promotes the development of retinoblastoma by regulating proliferation, cell cycle, migration, and invasion of retinoblastoma cells, Neurochem Res., 45, 2691, 10.1007/s11064-020-03112-0

Jiang, 2021, Circular RNA has_circ_0000034 accelerates retinoblastoma advancement through the miR-361-3p/ADAM19 axis, Mol Cell Biochem., 476, 69, 10.1007/s11010-020-03886-5

Zeng, 2019, Downregulation of CKS1B restrains the proliferation, migration, invasion and angiogenesis of retinoblastoma cells through the MEK/ERK signaling pathway, Int J Mol Med., 44, 103, 10.3892/ijmm.2019.4183

Wang, 2021, SCARA5 suppresses the proliferation and migration, and promotes the apoptosis of human retinoblastoma cells by inhibiting the PI3K/AKT pathway, Mol Med Rep., 23, 11841, 10.3892/mmr.2021.11841

Yeung, 2019, Comparison between Scopus, Web of Science, PubMed and publishers for mislabelled review papers, Curr Sci., 116, 1909, 10.18520/cs/v116/i11/1909-1914